# Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus

> **NCT07056803** · — · COMPLETED · sponsor: **University of Palermo** · enrollment: 212 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Oral semaglutide
- **DRUG:** subcutaneous semaglutide

## Key facts

- **NCT ID:** NCT07056803
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2024-06-25
- **Final completion:** 2025-06-25
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07056803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07056803, "Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07056803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*